Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2003
09/04/2003WO2003071863A2 Brassica seeds
09/04/2003WO2003030812A3 1-[(4-methyl thio)phenyl]-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same
09/04/2003WO2002088106A3 Cysteine protease inhibitors
09/04/2003US20030166978 Novel ruthenium complexes and process for preparing alcoholic compounds using these
09/04/2003US20030166949 Reactrting butyrolactone or valerolactone with formaldehyde;heating under critical temperature, critical pressure
09/04/2003US20030166931 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166930 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030165587 Production of 2-furfurylthiol in brassica seed and use of same
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2476038A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003CA2444940A1 Process for the production of citalopram
09/03/2003EP1340746A1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives
09/03/2003EP1339754A1 Multicomponent compositions containing chitosan and methods of preparing same
09/03/2003EP1339681A1 Synthesis of fused pyrrolecarboxamides
09/03/2003EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339664A1 Production of butane tetracarboxylic acid derivatives by means of coupled electrosynthesis
09/03/2003CN1440404A Benzofuran derivatives and their use as antibacterial agents
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440398A Substituted phthalides as anti-convulsive drugs
09/03/2003CN1440390A Substituted diamide derivatives useful as motilin antagonists
09/03/2003CN1440381A Process for preparation of substituted octanoyl amides
09/03/2003CN1440373A Process for the catalytic oxidation of hydrocarbons
09/03/2003CN1439636A Production of metaphenyltrimethyl anhydride from metatrimethylbenzene by solid bed gas phase oxidation
09/03/2003CN1439632A Sulfolipid compound with neural nourishing function and synthetic method and application thereof
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613919 Resolution with enantiomerically pure bases such as cinchonidine by forming a salt; also 3,4-dihydroxy-2(5H)-furanones
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613801 Method for the synthesis of compounds of formula I and their uses thereof
09/02/2003US6613787 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer
09/02/2003US6613782 For treating and/or preventing endothelin dependent conditions, e.g. cardio- and cerebro-vascular disorders such as hypertension, vasoconstriction, congestive heart failure, cerebral disorders, respiratory system disorders
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003070716A1 Vitamin d3 derivatives and remedies using the same
08/28/2003WO2003070715A1 An antimicrobial agent
08/28/2003WO2003070714A1 Fluorous acetylation
08/28/2003WO2003070680A1 Method for producing phthalic anhydride
08/28/2003WO2003049698A3 Substituted hydrazones as inhibitors of cyclooxygenase-2
08/28/2003WO2002036588A3 Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
08/28/2003WO2002000638A8 Substituted phthalides as anti-convulsive drugs
08/28/2003US20030162981 Contacting alkene or alkadiene with a catalyst consisting of bismuth, lead, molybdenum, oxygen, and at least one metal selected from the group consisting of copper, gold and vanadium in vapor-phase to form furan compound
08/28/2003US20030162961 Catalytic carbonylation of three and four membered heterocycles
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162282 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents
08/28/2003US20030162281 Intermediates and improved processes for the preparation of neplanocin A
08/28/2003CA2489498A1 An antimicrobial agent
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/27/2003EP1338594A1 Pgd2 receptor antagonistic pharmaceutical compositions
08/27/2003EP1337510A2 Synthesis and antimicrobial activityof novel dicationic "reversed amidines"
08/27/2003EP1337332A1 Catalyst and method for producing maleic anhydride
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1438223A Method for preparing effective anti-virus cyclopropane derivative and intermediate used thereof
08/27/2003CN1119339C Method and apparatus for direct oxygen injection with reactant stream into fluidized bed reactor
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119321C Asymmetric synthesis of chiral beta-amino acids
08/27/2003CN1119205C Process for preparation of improved vanadium-phosphorus catalysts and use thereof for production of maleic anhydride
08/26/2003US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
08/26/2003US6610863 Via contacting solution of 2-keto-L-gulonic acid with acid catalyst
08/26/2003US6610747 Phenoxybenzylamine derivatives as SSRIs
08/26/2003US6610743 Bicyclic metabotropic glutamate receptor ligands
08/26/2003US6610734 Heterocyclic sulfonamide inhibitors of beta amyloid production
08/26/2003US6610729 Hydroxamic acid derivatives and medicinal utilization thereof
08/26/2003US6610713 Treating cell with cholinergic agonist
08/26/2003US6610687 Benzofuranylsulfonates
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068946A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003WO2003068764A1 Process for the prepatation of ascorbic acid
08/21/2003WO2003068731A1 Beta-amino ketones for the treatment of pain
08/21/2003WO2003068723A1 Polyol ester compounds useful in preparation of a catalyst for olefins polymerization, process for preparing the same and use thereof
08/21/2003WO2003068204A1 Synthesis of substituted sulfonyl amines
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158425 Produced from butyrolactone and valerolactone by addition of formaldehyde in supercritical fluid in presence of catalyst and phase transfer agent
08/21/2003US20030158424 Substituted alpha, beta-anellated butyrolactones
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158194 Treating Congestive heart failure with a diethylamineethyloxy phenylketone benzofuran compounds
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003US20030157697 Intermediates and improved processes for the preparation of neplanocin A
08/21/2003CA2476618A1 Phenalenone derivatives, method for the production thereof and use of the same
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437583A Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
08/20/2003CN1437581A Glucagon antagonists/inverse agonists
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 472